Medication info
Amolantan Tablet 5/50 mg (Amlodipine, Losartan)

Amolantan Tablet 5/50 mg (Amlodipine, Losartan)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201502651 · Approved 2015.04.30 · Insurance code 649703180

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy or requiring initial combination therapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy or requiring initial combination therapy

  • Essential hypertension
  • Stage 2 hypertension
View approved original text

This medication is used when blood pressure control is difficult primarily in patients with essential hypertension, as it combines the effects of Amlodipine and Losartan. It is also effective in patients with Stage 2 hypertension who start treatment with a combination drug to reach their target blood pressure. This medication helps to stabilize blood pressure, improving blood pressure management and vascular health.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and must be discontinued immediately if pregnancy is confirmed. Patients with low blood volume or those taking diuretics should be cautious as blood pressure may drop too low when first taking this medication. Patients with allergies to the ingredients, severely impaired liver function, severe aortic stenosis, or in shock should not take this medication. Due to the blood pressure-lowering effect of this medication, side effects such as dizziness or drowsiness may occur, so caution is needed when engaging in hazardous activities like working at heights or driving. During the course of this medication, regular monitoring of liver and kidney function is required to check for abnormalities. This medication may enhance the blood pressure-lowering effect when taken with other antihypertensive drugs, so consultation with a doctor is necessary. Amlodipine should be avoided when taken with grapefruit juice, as it may excessively increase the blood pressure-lowering effect. This medication is not recommended for children and adolescents under 18 years of age, as its safety and efficacy in this population have not been established. Elderly patients over 75 years may face challenges with appropriate dosing of some ingredients, so caution is recommended during initial administration. Women who are pregnant or breastfeeding should not take this medication; if confirmed during use, it should be discontinued immediately and a physician consulted. Overdose may lead to severe hypotension or rapid heart rate, so the prescribed dosage must be strictly followed, and if abnormal symptoms occur, immediate medical attention is required. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may compromise quality.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • dependent edema
Show 177 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • frequency of urination
  • fatigue
  • edema
  • vasculitis
  • tension headache
  • sensory loss
  • sensory disturbances
  • peripheral neuropathy
  • syncope
  • gustatory disturbances
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • pancreatitis
  • vomiting
  • hyperglycemia
  • joint pain
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin flushing
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • angioedema
  • skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • hypotension
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • arm pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • irritability
  • panic disorder
  • sleep disorders
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • pulmonary congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning and pain in the eyes
  • conjunctivitis
  • taste distortion
  • tinnitus
  • decreased vision
  • nocturia
  • urinary tract infection
  • hypotension
  • shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • gustatory disturbances
  • dry cough
  • erythema
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • serum creatinine elevation
  • liver enzyme elevation
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius. Proper storage will help preserve the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.